• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Chewy Inc. (Amendment)

    8/7/23 4:06:12 PM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary
    Get the next $CHWY alert in real time by email
    SC 13G/A 1 ChewyIncCHWY.txt MS AMENDMENT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.9)* Chewy, Inc. ----------------------------------------------------- (Name of Issuer) Class A Common Stock ----------------------------------------------------- (Title of Class of Securities) 16679L109 ----------------------------------------------------- (CUSIP Number) July 31, 2023 ----------------------------------------------------- (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [x] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. SEC 1745 (3-06) CUSIP No.16679L109 13G Page 2 of 8 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON: I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: Morgan Stanley I.R.S. # 36-3145972 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY: -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware. -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER: SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER: EACH 5,204,516 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER: WITH: 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 6,520,266 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 6,520,266 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES: [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 5.6% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: HC, CO -------------------------------------------------------------------------------- CUSIP No.16679L109 13G Page 3 of 8 Pages -------------------------------------------------------------------------------- 1. NAME OF REPORTING PERSON: I.R.S. IDENTIFICATION NO. OF ABOVE PERSON: Morgan Stanley Investment Management Inc. I.R.S. # 13-3040307 -------------------------------------------------------------------------------- 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP: (a) [ ] (b) [ ] -------------------------------------------------------------------------------- 3. SEC USE ONLY: -------------------------------------------------------------------------------- 4. CITIZENSHIP OR PLACE OF ORGANIZATION: Delaware. -------------------------------------------------------------------------------- NUMBER OF 5. SOLE VOTING POWER: SHARES 0 BENEFICIALLY -------------------------------------------------------------- OWNED BY 6. SHARED VOTING POWER: EACH 5,089,083 REPORTING -------------------------------------------------------------- PERSON 7. SOLE DISPOSITIVE POWER: WITH: 0 -------------------------------------------------------------- 8. SHARED DISPOSITIVE POWER: 6,401,278 -------------------------------------------------------------------------------- 9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON: 6,401,278 -------------------------------------------------------------------------------- 10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES: [ ] -------------------------------------------------------------------------------- 11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9): 5.5% -------------------------------------------------------------------------------- 12. TYPE OF REPORTING PERSON: IA, CO -------------------------------------------------------------------------------- CUSIP No.16679L109 13G Page 4 of 8 Pages -------------------------------------------------------------------------------- Item 1. (a) Name of Issuer: Chewy, Inc. -------------------------------------------------------------- (b) Address of Issuer's Principal Executive Offices: 7700 WEST SUNRISE BOULEVARD PLANTATION FL 33322 UNITED STATES OF AMERICA -------------------------------------------------------------- Item 2. (a) Name of Person Filing: (1) Morgan Stanley (2) Morgan Stanley Investment Management Inc. -------------------------------------------------------------- (b) Address of Principal Business Office, or if None, Residence: (1) 1585 Broadway New York, NY 10036 (2) 522 5th Avenue 6th Floor New York, NY 10036 -------------------------------------------------------------- (c) Citizenship: (1) Delaware. (2) Delaware. -------------------------------------------------------------- (d) Title of Class of Securities: Class A Common Stock -------------------------------------------------------------- (e) CUSIP Number: 16679L109 -------------------------------------------------------------- Item 3. If this statement is filed pursuant to Sections 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o). (b) [ ] Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c). (c) [ ] Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c). (d) [ ] Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8). (e) [x] An investment adviser in accordance with Sections 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [x] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] A non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); (k) [ ] Group, in accordance with sections 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with sections 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Not Applicable CUSIP No.16679L109 13G Page 5 of 8 Pages -------------------------------------------------------------------------------- Item 4. Ownership as of July 31, 2023.* (a) Amount beneficially owned: See the response(s) to Item 9 on the attached cover page(s). (b) Percent of Class: See the response(s) to Item 11 on the attached cover page(s). (c) Number of shares as to which such person has: (i) Sole power to vote or to direct the vote: See the response(s) to Item 5 on the attached cover page(s). (ii) Shared power to vote or to direct the vote: See the response(s) to Item 6 on the attached cover page(s). (iii) Sole power to dispose or to direct the disposition of: See the response(s) to Item 7 on the attached cover page(s). (iv) Shared power to dispose or to direct the disposition of: See the response(s) to Item 8 on the attached cover page(s). Item 5. Ownership of Five Percent or Less of a Class. Not Applicable Item 6. Ownership of More Than Five Percent on Behalf of Another Person. Not Applicable Item 7. Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company. See Exhibit 99.2 Item 8. Identification and Classification of Members of the Group. Not Applicable Item 9. Notice of Dissolution of Group. Not Applicable Item 10. Certification. (1) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. * In Accordance with the Securities and Exchange Commission Release No. 34-39538 (January 12, 1998) (the "Release"), this filing reflects the securities beneficially owned, or that may be deemed to be beneficially owned, by certain operating units (collectively, the "MS Reporting Units") of Morgan Stanley and its subsidiaries and affiliates (collectively, "MS"). This filing does not reflect securities, if any, beneficially owned by any operating units of MS whose ownership of securities is disaggregated from that of the MS Reporting Units in accordance with the Release. CUSIP No.16679L109 13G Page 6 of 8 Pages -------------------------------------------------------------------------------- Signature After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: August 07, 2023 Signature: /s/ Christopher O'Hara -------------------------------------------------------------------- Name/Title: Christopher O'Hara/Authorized Signatory, Morgan Stanley -------------------------------------------------------------------- MORGAN STANLEY Date: August 07, 2023 Signature: /s/ Deidre A. Downes -------------------------------------------------------------------- Name/Title: Deidre A. Downes/Authorized Signatory, Morgan Stanley Investment Management Inc. -------------------------------------------------------------------- Morgan Stanley Investment Management Inc. EXHIBIT NO. EXHIBITS PAGE ----------- ---------- ---- 99.1 Joint Filing Agreement 7 99.2 Item 7 Information 8 * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). CUSIP No.16679L109 13G Page 7 of 8 Pages -------------------------------------------------------------------------------- EXHIBIT NO. 99.1 TO SCHEDULE 13G JOINT FILING AGREEMENT --------------------------------------------------- August 07, 2023 --------------------------------------------------- MORGAN STANLEY and Morgan Stanley Investment Management Inc. hereby agree that, unless differentiated, this Schedule 13G is filed on behalf of each of the parties. MORGAN STANLEY BY: /s/ Christopher O'Hara --------------------------------------------------------------------- Christopher O'Hara/Authorized Signatory, Morgan Stanley Morgan Stanley Investment Management Inc. BY: /s/ Deidre A. Downes --------------------------------------------------------------------- Deidre A. Downes/Authorized Signatory, Morgan Stanley Investment Management Inc. * Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). CUSIP No.16679L109 13G Page 8 of 8 Pages -------------------------------------------------------------------------------- EXHIBIT NO. 99.2 ------------------ ITEM 7 INFORMATION The securities being reported on by Morgan Stanley as a parent holding company are owned, or may be deemed to be beneficially owned, by Morgan Stanley Investment Management Inc., a wholly-owned subsidiary of Morgan Stanley.
    Get the next $CHWY alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $CHWY

    DatePrice TargetRatingAnalyst
    3/24/2025Neutral
    Seaport Research Partners
    1/23/2025Hold → Buy
    Argus
    1/13/2025$34.00 → $47.00In-line → Outperform
    Evercore ISI
    1/6/2025$24.00 → $42.00Neutral → Outperform
    Mizuho
    1/3/2025Peer Perform → Outperform
    Wolfe Research
    12/5/2024Outperform → Neutral
    Exane BNP Paribas
    11/20/2024$24.00 → $40.00Underperform → Buy
    BofA Securities
    11/8/2024$28.00 → $40.00Neutral → Buy
    Citigroup
    More analyst ratings

    $CHWY
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    See more
    • December 14, 2023 - FDA Warns Nine Manufacturers, Distributors of Unapproved Antimicrobials for Animals

      For Immediate Release: December 14, 2023 Today, the U.S. Food and Drug Administration is announcing the issuance of nine warning letters to manufacturers and distributors of unapproved and misbranded antimicrobial animal drugs for violations of federal law. The agency is concerned because these products contain antimicrobials that are important in human medicine and using them without medical oversight contribut

      12/14/23 9:00:20 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Executive Officer Singh Sumit sold $8,826,525 worth of shares (208,090 units at $42.42), decreasing direct ownership by 30% to 497,162 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      5/20/25 4:10:06 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chief Executive Officer Singh Sumit sold $8,056,695 worth of shares (198,806 units at $40.53), decreasing direct ownership by 22% to 705,252 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      5/15/25 4:44:06 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chief Executive Officer Singh Sumit sold $2,168,447 worth of shares (59,417 units at $36.50), decreasing direct ownership by 6% to 904,058 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      5/6/25 4:09:54 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Financials

    Live finance-specific insights

    See more
    • Chewy Announces Fiscal First Quarter 2025 Financial Results Conference Call

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal first quarter 2025 financial results before the market opens on Wednesday, June 11, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed

      5/9/25 8:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal Fourth Quarter and Full Year 2024 Financial Results

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, has released its financial results for the fiscal fourth quarter and full year 2024 ended February 2, 2025. Fiscal Q4 2024 Results (1): Net sales of $3.25 billion improved 14.9 percent year over year Gross margin of 28.5 percent expanded 30 basis points year over year Net income of $22.8 million, including share-based compensation expense and related taxes of $99.7 million Net margin of 0.7 percent declined 40 basis points year over year Basic earnings per share of $0.06, a decrease of $0.01 year over year Diluted earnings per share of $0.05, a decrease of $0.02 year over year Ad

      3/26/25 7:05:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal Fourth Quarter and Full Year 2024 Financial Results Conference Call

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal fourth quarter and full year 2024 financial results before the market opens on Wednesday, March 26, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live webcast and

      3/3/25 4:05:00 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Seaport Research Partners initiated coverage on Chewy

      Seaport Research Partners initiated coverage of Chewy with a rating of Neutral

      3/24/25 7:44:34 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy upgraded by Argus

      Argus upgraded Chewy from Hold to Buy

      1/23/25 7:35:58 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy upgraded by Evercore ISI with a new price target

      Evercore ISI upgraded Chewy from In-line to Outperform and set a new price target of $47.00 from $34.00 previously

      1/13/25 7:35:38 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Press Releases

    Fastest customizable press release news feed in the world

    See more

    $CHWY
    SEC Filings

    See more

    $CHWY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chewy CFO David Reeder to Depart Chewy, Company Reaffirms First Quarter Guidance

      Chewy, Inc. (NYSE:CHWY), a trusted destination for pet parents and partners everywhere, announced today that the Company's Chief Financial Officer, David Reeder, will be departing in several months to return to the semiconductor industry as a Chief Executive Officer. "We appreciate David's contributions during his time at Chewy and thank him for his leadership as we advanced our strategic, long-term growth initiatives," said Sumit Singh, Chief Executive Officer of Chewy. "As discussed on our March 26th earnings call, our long term plan remains intact, our business momentum remains strong, and we are reaffirming our guidance for the first quarter. David will remain as CFO through our next e

      5/12/25 7:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Fiscal First Quarter 2025 Financial Results Conference Call

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that it will report fiscal first quarter 2025 financial results before the market opens on Wednesday, June 11, 2025. Management will host a conference call and webcast to discuss the company's financial results at 8:00 am ET. To access the conference call by phone, please visit this link for registration (Phone Registration Link) to be provided with dial in details, including a unique PIN to access the conference call. To avoid delays, we encourage participants to register in advance or at a minimum 15 minutes before the start of the call. A live audio webcast can be accessed

      5/9/25 8:30:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Chewy Announces Participation in J.P. Morgan's 53rd Annual Global Technology, Media and Communications Conference

      Chewy, Inc. (NYSE:CHWY) ("Chewy"), a trusted destination for pet parents and partners everywhere, announced today that the company will participate in a fireside chat at the J.P. Morgan Annual Global Technology, Media and Communications Conference on May 14, 2025 at 10:00 AM ET. A live audio webcast can be accessed on the company's investor relations website at https://investor.chewy.com and a replay will be accessible for 30 days following the event. About Chewy Our mission is to be the most trusted and convenient destination for pet parents and partners everywhere. We believe that we are the preeminent online source for pet products, supplies and prescriptions as a result of our broad

      5/8/25 4:05:00 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form DEFA14A filed by Chewy Inc.

      DEFA14A - Chewy, Inc. (0001766502) (Filer)

      5/23/25 7:06:06 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form DEF 14A filed by Chewy Inc.

      DEF 14A - Chewy, Inc. (0001766502) (Filer)

      5/23/25 7:05:30 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • SEC Form SCHEDULE 13G filed by Chewy Inc.

      SCHEDULE 13G - Chewy, Inc. (0001766502) (Subject)

      5/15/25 4:07:03 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Star James A bought $249,519 worth of shares (12,242 units at $20.38), increasing direct ownership by 9% to 141,790 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/18/23 4:09:39 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Star James A bought $300,992 worth of shares (15,353 units at $19.60), increasing direct ownership by 13% to 129,548 units (SEC Form 4)

      4 - Chewy, Inc. (0001766502) (Issuer)

      12/14/23 4:10:59 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary

    $CHWY
    Leadership Updates

    Live Leadership Updates

    See more
    • Chewy Set to Join S&P MidCap 400

      NEW YORK, Nov. 1, 2024 /PRNewswire/ -- Chewy Inc. (NYSE: CHWY) will replace Stericycle Inc. (NASD: SRCL) in the S&P MidCap 400 effective prior to the opening of trading on Wednesday, November 6. S&P 500 constituent Waste Management Inc. (NYSE:WM) is acquiring Stericycle in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector November 6, 2024 S&P MidCap 400 Addition Chewy CHWY Consumer Discretionary November 6, 2024 S&P MidCap 400 Deletion Stericycle SRCL Industrial For more information about

      11/1/24 7:11:00 PM ET
      $CHWY
      $SPGI
      $SRCL
      $WM
      Catalog/Specialty Distribution
      Consumer Discretionary
      Finance: Consumer Services
      Finance
    • Chewy Appoints Mark Eamer as Chief Marketing Officer

      Seasoned Leader to Spearhead Continued Expansion of Chewy's Marketing and Customer Engagement Capabilities Chewy, Inc. ("Chewy") (NYSE:CHWY), a leading online destination for pet parents and partners, announced today the appointment of Mark Eamer as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210930005601/en/Chewy Appoints Mark Eamer as Chief Marketing Officer (Photo: Business Wire) As CMO, Mark will spearhead the continued expansion of Chewy's Marketing and Customer Engagement capabilities, with ownership of the company's marketing strategy, partnerships and analytics, including full funnel cus

      9/30/21 9:00:00 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • GameStop Announces Additional Board Refreshment to Accelerate Transformation

      Aligns with Ryan Cohen of RC Ventures on the Immediate Appointment of Three New Directors with Significant E-Commerce and Technology Experience Confirms the Board’s Commitment to Supporting GameStop’s Pursuit of Growth and Market Leadership GRAPEVINE, Texas, Jan. 11, 2021 (GLOBE NEWSWIRE) -- GameStop Corp. (NYSE: GME) (“GameStop” or the “Company”) today announced that it has entered into an agreement with RC Ventures LLC (“RC Ventures”) that will advance the refreshment of the Company’s Board of Directors (the “Board”). RC Ventures, which is one of the Company’s largest stockholders, is managed by Ryan Cohen. The agreement provides for the immediate appointment of three new directors –

      1/11/21 7:30:00 AM ET
      $CHWY
      $GME
      Catalog/Specialty Distribution
      Consumer Discretionary
      Electronics Distribution

    $CHWY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/12/24 2:29:11 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/6/24 4:39:56 PM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary
    • Amendment: SEC Form SC 13G/A filed by Chewy Inc.

      SC 13G/A - Chewy, Inc. (0001766502) (Subject)

      11/4/24 11:23:07 AM ET
      $CHWY
      Catalog/Specialty Distribution
      Consumer Discretionary